Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $3.28 USD
Change Today -0.12 / -3.53%
Volume 300.0
BONE On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

bacterin international holdi (BONE) Snapshot

Open
$3.28
Previous Close
$3.40
Day High
$3.28
Day Low
$3.28
52 Week High
07/7/14 - $7.40
52 Week Low
11/20/14 - $2.19
Market Cap
23.2M
Average Volume 10 Days
39.0K
EPS TTM
$-4.72
Shares Outstanding
7.1M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for BACTERIN INTERNATIONAL HOLDI (BONE)

Related News

No related news articles were found.

bacterin international holdi (BONE) Related Businessweek News

No Related Businessweek News Found

bacterin international holdi (BONE) Details

Bacterin International Holdings, Inc. develops, manufactures, and markets biologics products in the United States and internationally. The company offers products that are used in various applications, including enhancing fusion in spine surgery, relief of back pain with a facet joint stabilization, promotion of bone growth in foot and ankle surgery, promotion of skull healing, neurosurgery, and regeneration in knee and other joint surgeries. Its products include OsteoSponge, which provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC, a subchondral bone void filler; OsteoSelect DBM putty, an osteoinductive product used by surgeons as a bone void filler in the extremities and pelvis; and OsteoWrap that wraps around non-union fractures to assist with fusion, and could be used in conjunction with a hardware plate system. The company also provides OsteoLock and BacFast HD facet stabilization dowels that are used to augment spinal procedures; OsteoSTX for posterolateral spine surgery applications, including scoliosis procedures; and hMatrix dermal scaffold, which promotes cellular ingrowth, tissue vascularization, and regeneration. In addition, it processes and sells sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. Further, the company’s products include 3Demin cortical fibers, 3Demin boats, and 3Demin strips made from cortical bone and primarily used in spine procedures. It markets its products through direct sales, as well as through distributor relationships. Bacterin International Holdings, Inc. is headquartered in Belgrade, Montana.

148 Employees
Last Reported Date: 03/18/15

bacterin international holdi (BONE) Top Compensated Officers

Chief Executive Officer
Total Annual Compensation: $500.2K
President
Total Annual Compensation: $153.8K
Chief Financial Officer, Treasurer and Secret...
Total Annual Compensation: $350.0K
Chief Operating Officer
Total Annual Compensation: $338.6K
Chief Scientific Officer
Total Annual Compensation: $271.1K
Compensation as of Fiscal Year 2014.

bacterin international holdi (BONE) Key Developments

Bacterin International Holdings and Premier to Develop Longer Term Programmes to Improve Patient Care Nationwide

Bacterin International Holdings revealed the launch of a new group purchasing agreement for the Bone Tissue Synthetic Implantable Products Category with Premier. With effect from July 1, 2015, the new agreement enables Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated of contracted product portfolio for its members.

Bacterin International Announces Signing of Agreement with Yankee Alliance

Bacterin International Holdings, Inc. announced the signing of an agreement with Yankee Alliance. The agreement covers Bacterin's complete line of biologic implants, including 3Demin cortical fiber allografts. The contract is a three-year agreement extending through June 2018. This is the first GPO to include Bacterin's 3Demin family of allografts. The 3Demin Boats, Strips, and Fibers were developed to compete in the domestic bone replacement market, a $1.7 billion annual business segment, and serve as a complement to the proprietary demineralized bone matrix (DBM) portfolio. Since launching 3Demin in late 2014, Bacterin has experienced positive adoption of this new allograft category and anticipates it will continue to contribute to Bacterin's growth. In addition to this agreement, Yankee Alliance has access to Bacterin's full product portfolio of allografts through their affiliation with Premier, Inc., in which Bacterin serves as a contracted biologics supplier.

Bacterin International Holdings, Inc. Announces the Launch of ArthroFuse(TM)

Bacterin International Holdings, Inc. announced the release of ArthroFuse, a patent pending allograft specifically designed for the treatment of hammertoe deformities. Hammertoe deformity affects the proximal interphalangeal joint of the lesser metatarsals and often resulting in debilitating joint pain and disability. While 550,000 surgical hammertoe procedures are performed each year in the United States it is thought that the majority of an estimated 60 million affected adults go undiagnosed. Current surgical options include screws, staples, pins and intermedulary implants. Bacterin's novel approach to this affliction eliminates the need for externally communicating pins or permanent implants by providing an implant that will remodel over time into the patient's own bone. ArthroFuse is an addition to Bacterin's allograft catalog, specifically targeted to foot and ankle surgeons active in the $500 million to $1 billion (est) Hammertoe implant market.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BONE:US $3.28 USD -0.12

BONE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alphatec Holdings Inc $1.39 USD +0.01
Exactech Inc $20.86 USD -0.02
RTI Surgical Inc $6.29 USD -0.07
SeaSpine Holdings Corp $18.54 USD -0.57
Wright Medical Group Inc $26.08 USD +0.03
View Industry Companies
 

Industry Analysis

BONE

Industry Average

Valuation BONE Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.6x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BACTERIN INTERNATIONAL HOLDI, please visit www.bacterin.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.